PPP1R1B and major depressive disorder: DARPP-32 is involved in the regulation of dopaminergic and glutaminergic signaling, and it has been implicated in various neurological and psychiatric disorders including schizophrenia (Albert et al., 2002) and depression (Svenningsson et al., 2002).